Propensity4 developed a dual arch-typing approach


Combining Clinical and Community KOLs transforms MSL targeting, enabling impactful engagement that advances therapeutic adoption and patient outcomes.

Jump to a slide with the slide dots.
We’re thrilled to announce that Isabelle Amick has joined Propensity4 as our new Senior Director of Data Science!
Read more
End-to-end US launch support for EU client’s dry eye device—from KAM team and CRM setup to data analytics, targeting, and incentive strategy.
Read more
This blog explores how “bottom-up” forecasting, particularly Most Probable Forecasting (MPF), enhances pharmaceutical brand planning.
Read more
Personalized patient engagement boosted therapy adherence with AI-driven insights, risk scoring, and tailored support recommendations.
Read more
Accelerating rare disease diagnosis through data-driven patient finding and predictive modeling to connect patients with the right HCPs faster.
Read more